Page last updated: 2024-11-05

trimipramine and Mastocytosis, Systemic

trimipramine has been researched along with Mastocytosis, Systemic in 1 studies

Trimipramine: Tricyclic antidepressant similar to IMIPRAMINE, but with more antihistaminic and sedative properties.
trimipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)-2-methylpropyl group at the nitrogen atom. It is used as an antidepressant.

Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klepper, L1
Tronnier, M1

Other Studies

1 other study available for trimipramine and Mastocytosis, Systemic

ArticleYear
[Multiple fibromas in systemic mastocytosis].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2005, Volume: 3, Issue:5

    Topics: Aged; Antidepressive Agents, Tricyclic; Antipruritics; Biopsy; Fibroma; Histocytochemistry; Humans;

2005